Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Medtronic
Dow
Mallinckrodt
McKinsey

Last Updated: May 22, 2022

Investigational Drug Information for Aldoxorubicin


✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for Aldoxorubicin?

Aldoxorubicin is an investigational drug.

There have been 20 clinical trials for Aldoxorubicin. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2014.

The most common disease conditions in clinical trials are Neoplasms, Sarcoma, and Pancreatic Neoplasms. The leading clinical trial sponsors are ImmunityBio, Inc., CytRx, and NantKwest, Inc.

There are twenty-three US patents protecting this investigational drug and three hundred and twenty-six international patents.

Recent Clinical Trials for Aldoxorubicin
TitleSponsorPhase
Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for First and Second Line Treatment of Locally Advanced or Metastatic Pancreatic CancerImmunityBio, Inc.Phase 2
QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) VaccineImmunityBio, Inc.Phase 2
QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) VaccineNantKwest, Inc.Phase 2

See all Aldoxorubicin clinical trials

Clinical Trial Summary for Aldoxorubicin

Top disease conditions for Aldoxorubicin
Top clinical trial sponsors for Aldoxorubicin

See all Aldoxorubicin clinical trials

US Patents for Aldoxorubicin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Aldoxorubicin See Plans and Pricing Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) See Plans and Pricing
Aldoxorubicin See Plans and Pricing Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2 Biomed Valley Discoveries, Inc. (Kansas City, MO) Vertex Pharmaceuticals Incorporated (Boston, MA) See Plans and Pricing
Aldoxorubicin See Plans and Pricing Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) See Plans and Pricing
Aldoxorubicin See Plans and Pricing Anthracycline formulations CytRx Corporation (Los Angeles, CA) See Plans and Pricing
Aldoxorubicin See Plans and Pricing Compartmented pharmaceutical dosage forms Triastek, Inc. (Nanjing, CN) See Plans and Pricing
Aldoxorubicin See Plans and Pricing Enzyme-responsive peptide nanofiber compositions and uses thereof CORNELL UNIVERSITY (Ithaca, NY) See Plans and Pricing
Aldoxorubicin See Plans and Pricing Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof RACE ONCOLOGY LTD. (Melbourne, AU) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Aldoxorubicin

Drugname Country Document Number Estimated Expiration Related US Patent
Aldoxorubicin Australia AU2017261372 2036-05-05 See Plans and Pricing
Aldoxorubicin Canada CA3023278 2036-05-05 See Plans and Pricing
Aldoxorubicin China CN107847398 2036-05-05 See Plans and Pricing
Aldoxorubicin European Patent Office EP3452003 2036-05-05 See Plans and Pricing
Aldoxorubicin Hong Kong HK1249728 2036-05-05 See Plans and Pricing
Aldoxorubicin Japan JP2019520866 2036-05-05 See Plans and Pricing
Aldoxorubicin Japan JP6559912 2036-05-05 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Medtronic
Dow
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.